Ads
related to: metastatic prostate cancer- New Clinical Trial Data
Review the New Indication Based on
The Results of a Clinical Trial.
- Patient Resource Download
Download Patient Brochure and
XTANDI Support Solutions® Pamphlet.
- Clinical Trial Data
View Updated Data and Results
From a Pivotal Trial for XTANDI®.
- Dosing & Administration
Download Patient Brochure and
View Dose Modifications.
- Clinical Guidelines
Review Clinical Guidelines That
Support the Use of XTANDI®.
- Prescribing Information
View Prescribing Information
For XTANDI® (enzalutamide).
- New Clinical Trial Data
Search results
Urine Test Could Prevent Unnecessary Prostate Biopsies
Medscape· 6 days agoProstate cancer screening tests lack specificity in detecting higher-grade tumors, but a new urine...
Study identifies differences in prostate cancer genomics among a racially and ethnically diverse...
Medical Xpress· 5 days agoA new study led by a UCLA-VA collaborative team looking at the landscape of genomic alterations in...
Study: This Diet Has Been Linked to Reducing Risk of Prostate Cancer Progression
Health.com· 6 days agoNow, a new study suggests that the eating plan may slow the progression of prostate cancer. The...
Chicago Cubs Legend Provides Positive Health Update
Sports Illustrated· 6 days agoIn January, Chicago Cubs legend Ryne Sandberg announced that he was undergoing treatment for metastatic prostate cancer. Sandberg said ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoSan Francisco of FG-3246 (FOR46), a potential first-in-class anti-CD46 antibody drug conjugate (ADC) with a MMAE-containing payload, in combination with enzalutamide in patients with
Mumbai doctors treat 77-year-old Zambian man with triple cancers
Investing.com· 7 days agoMumbai, May 23 (IANS) A 77-year-old man from Zambia was given a new life by doctors here after...
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
Zacks via Yahoo Finance· 1 day agoCandel (CADL) surges 431% in the year-to-date period, driven by positive developmental and...
Advances in highly targeted radiation treatment for cancer have ignited interest in a once obscure...
Nature· 1 day agoTherapies that treat while diagnosing — theranostics — can extend length of survival and improve the...
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 6 days agoJNJ-6420 is an anti-hK2 antibody-based targeted radioligand therapy that's designed to deliver a...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 6 days agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...